Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials.
Wanting HouMingfu DingXiaohua LiXiaohan ZhouQing ZhuArmando Varela-RamirezCheng YiPublished in: Journal of cancer research and clinical oncology (2021)
CRD 42,020,167,307.